RecruitingNot ApplicableNCT05243069

Head and Neck Cancer Patient Symptom and Oncologic Outcomes

Head and Neck Cancer Patient Symptom and Oncologic Outcomes as a Function of Head and Neck Volume Changes

Sponsor

Ohio State University Comprehensive Cancer Center

Enrollment

80 participants

Start Date

Mar 31, 2023

Study Type

INTERVENTIONAL

Conditions

Lymphedema of the Head and Neck

Summary

This trial investigates a new approach using a mobile three-dimensional (3D) scanning application for volumetric measurement of the head and neck region in patients with head and neck lymphedema. Lymphedema is the buildup of extra lymph fluid in tissues that causes swelling. Accurate volumetric measurements of swelling are crucial to the diagnosis of lymphedema and to monitoring response to therapy and disease progression over time. A mobile 3D surface scanning application may help doctors measure and analyze swelling in patients with head and neck lymphedema.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tracks symptoms and cancer treatment outcomes in patients with head and neck cancer, with a specific focus on lymphedema (swelling) that can occur in the head and neck area after treatment. Researchers aim to better understand and manage these side effects. **You may be eligible if...** - You have a condition that has led to, or is likely to lead to, lymphedema in the head and neck area - You have minimal or no facial hair (which helps with certain assessments) - You can understand the study and make your own decisions **You may NOT be eligible if...** - You have health conditions or a history of not following medical instructions that would interfere with the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.